Tranexamic acid: more evidence for its use in joint replacement surgery.

Transfusion

Department of Anesthesia, Toronto Western Hospital University Health Network, University of Toronto, Toronto, Ontario, Canada.

Published: January 2014

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12494DOI Listing

Publication Analysis

Top Keywords

tranexamic acid
4
acid evidence
4
evidence joint
4
joint replacement
4
replacement surgery
4
tranexamic
1
evidence
1
joint
1
replacement
1
surgery
1

Similar Publications

Background: Hemoptysis, the expectoration of blood from the lower respiratory tract, varies in severity and necessitates effective management to mitigate morbidity. Traditional treatments include bronchial artery embolization and pharmacological approaches. Tranexamic acid (TXA), an antifibrinolytic agent known for its efficacy in reducing bleeding during surgery and trauma, is being explored for its efficacy in treating Hemoptysis via both intravenous and inhalational routes.

View Article and Find Full Text PDF

Integrative analyses of mendelian randomization and bioinformatics reveal casual relationship and genetic links between COVID-19 and knee osteoarthritis.

BMC Med Genomics

January 2025

Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention, Ministry of Education, College of Pharmacy, Chongqing Medical University, Chongqing, 400016, China.

Background: Clinical and epidemiological analyses have found an association between coronavirus disease 2019 (COVID-19) and knee osteoarthritis (KOA). Infection with COVID-19 may increase the risk of developing KOA.

Objectives: This study aimed to investigate the potential causal relationship between COVID-19 and KOA using Mendelian randomization (MR) and to explore the underlying mechanisms through a systematic bioinformatics approach.

View Article and Find Full Text PDF

Background: Jehovah's Witness patients refuse blood transfusion because of their religious beliefs making total hip arthroplasty (THA) challenging. This study aims to determine the safety of THA in Jehovah's Witness patients using standard perioperative protocols as well as evaluate the effectiveness of tranexamic acid (TXA) in controlling blood loss.

Methods: Databases from two tertiary academic centers were queried from 2003 to 2021 to identify THA patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!